Skip to content

Clinical trials

Phase 2 Inflammation trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2 Status: Unknown status Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20073
20081
20093
20102
20112
20121
20132
20161
20171
20185
20195
20202
20213
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital2
101 Therapeutics1
Baltimore VA Medical Center1
CCTU-Core1
Centre Hospitalier Universitaire de Besancon1
Claes-Göran Östenson1
Coordinación de Investigación en Salud, Mexico1
Critical Therapeutics1
Immunitor LLC1
Institute for Atherosclerosis Research, Russia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation36
Insulin Resistance5
Atherosclerosis3
COVID-193
Diabetes Mellitus3
Diabetes Mellitus, Type 23
Arthritis2
Autoimmune Diseases2
Kidney Failure, Chronic2
Pathologic Processes2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.